The Delta type increases the risk of hospital stay — but the vaccine is still working

Good news? The vaccine also reduces the risk of hospital admissions by the Delta variety. A Scottish study found that the Pfizer / BioNTech vaccine provides 79% protection, two weeks from the second level, while the Oxford / AstraZeneca vaccine provides 60% protection. This decline could be due to the fact that it takes longer for adequate protection to have the Oxford / AstraZeneca vaccine, researchers said.

However, research was recently released by Public Health England it was very promising. It found that the Pfizer / BioNTech vaccine provides 96% protection in hospital after receiving two drugs, while Oxford / AstraZeneca is 92% effective in preventing hospitalization after a full shot. Finally? This is another important testament to the fact that more people are vaccinated, and that both people are shooting.

Infectious: Delta’s difference in shipping is 64% higher than the Alpha type in the home, according to Public Health England.

This, combined with clinical awareness, is why the UK has delayed plans to raise residual covid-19 residual monthly restrictions. The hope is that these extra weeks will provide more time to encourage older people with adequate immunizations. Although more than 70% of the UK have one level, more than half have both.

Great fear: Worryingly, since the program received the vaccine, it is now that the current vaccine will not be effective because the virus changes and changes, which is known as “Vaccine escape.” As it stands here, it seems to have not happened. But eventually we will need a new vaccine designed to be able to deal with other species.